Log In
Print this Print this


Also known as: formerly MKC-253

  Manage Alerts
Collapse Summary General Information
Company MannKind Corp.
DescriptionFormulation of glucagon-like peptide-1 (GLP-1) delivered on Technosphere particles
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today